India faces mounting vulnerability due to its soaring dependence on imported crude oil, now exceeding 90%. A recent EY report urges augment...

India's fiscal deficit is expected to remain under control in FY27, thanks to robust nominal GDP growth driven by higher inflation, accordi...

NSE's proposed IPO could value the exchange at around Rs 5 lakh crore, making it one of India's most valuable listed financial institutions...

In FY26, Sanjiv Puri, the Chairman and Managing Director of ITC, saw his total compensation decline by 6.8% to Rs 23.91 crore. This reducti...

ITC Chairman and Managing Director Sanjiv Puri's total pay saw a 6.8% dip to Rs 23.91 crore in FY26, primarily due to lower performance bon...

Laurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...

On This Day in History, June 26 saw the signing of the United Nations Charter, Richard III's rise to the English throne, India's declaratio...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

India’s audit market in FY26 remained dominated by large firms, with EY, KPMG and Deloitte leading by audit volume and market capitalisatio...

Affordable housing finance companies are poised for a growth rebound from FY27, according to Kotak Institutional Securities. After a subdue...

Infosys CEO Salil Parekh led the pack among top Indian IT executives in FY26, earning Rs 82.6 crore. Tech Mahindra's Mohit Joshi followed w...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...

India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...

L’Oréal has bought Innovist to claw back momentum in India’s hyper-competitive beauty market. This and more in today’s ETtech Top 5.

The company had reported net operating income of Rs 795 crore and a profit after tax of Rs 408 crore in FY25. The rating agency attributed ...